RxDoctor Payments Data

Pascal Scemama de Gialluly, MD

Anesthesiology · Worcester, MANPI 1417262015

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Bioventus LLC at 52.1% of the total. Reporting peaked in 2023 at $12,141 and has fallen 64.8% since, to $4,276 in 2024. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,677in general payments, 2019–2025

Across 123 payments — averaging $265.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$17K
  • Abbott$3K
  • Medtronic$3K
  • Bioness Inc$2K
  • Vertex$2K
  • Nalu Medical, Inc.$2K
  • plus $3K from 14 others

What the payments were for

  • Consulting fees$3,25510%
  • Speaking & faculty fees$14,40044%
  • Travel & lodging$6,26119%
  • Food & beverage$6,68920%
  • Education$1,6005%
  • Entertainment$4721%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,677 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$47,377
Medicare patients
175
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin16$107
Pregabalin12$89

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →